Experience

Zedsen

• United Kingdom
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Clinical Trial Manager

  • Jul 2022 - Present



Imperial College London

• Research Services
• 700 & Above Employee

• Team Lead/Clinical Trial Coordinator

  • Mar 2020 - Jul 2022

  Team lead for the Breast Translational Research Group.Project management of clinical trials and studies in breast and prostate cancer.

• Clinical Trial Coordinator

  • Feb 2019 - May 2020

  Project management and development of surgical trial portfolio in breast cancer.

• Clinical Research Assistant

  • Sep 2015 - Feb 2019

  Project management of NIHR BioAID (Bioresource for Adult Infectious Disease) research across 3 Imperial College Trust sites and ensuring study compliance with ICH-GCP.Responsible for patient recruitment and follow up, sample collection and transportation, development of study documentation (protocols, consent forms, CRF) and ethics submission using IRAS, data collection using EPR systems, data management and analyses, development of study database and eCRF using RedCap, maintaining ISF/eISF, liaison with key stakeholders including clinicians, sponsors, and other researchers. Show less



Chang-Gung Memorial Hospital, Linkou

• Taiwan

• Research Assistant

  • Jan 2013 - Jul 2014

  Responsible for patient recruitment and follow up in different trials and studies within the Gynaecological Oncology Department. Also responsible for study budget management and liaison with key stakeholders. Organisation of and preparation of documentation for audit, monitoring visits, and study initiation meetings with sponsors. Involved in writing research proposals and obtaining ethics from IRB. Participated in manuscript preparation and submission. Other responsibilities include laboratory work as needed and tissue collection from theatre. Show less



Kaohsiung Medical University

• Taiwan

• Intern

  • Jun 2012 - Aug 2012

  Investigated promoter methylation of MUC1 and HOPX-β in human tissue samples, which may act as potential biomarkers for oesophageal cancer. Investigated promoter methylation of MUC1 and HOPX-β in human tissue samples, which may act as potential biomarkers for oesophageal cancer.